Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Pharmaco (NZ) Ltd takes on a new frontier

4th November 2013

Pharmaco (NZ) Ltd takes on a new frontier

Healthcare sales, marketing and distribution specialist Pharmaco (NZ) Limited has announced today it has acquired Frontier Medical New Zealand Limited a sales and distribution company specialising in the emergency medical care and equipment sector.

The acquisition of Frontier Medical will open up an entirely new business sector for Pharmaco in the area of providing critical products to pre-hospital emergency services such as fire, ambulance, Coastguard, Police and the Defence force, as well as hospital emergency services.

Under the agreement Pharmaco will sell, market and distribute over 1,000 products currently managed by Frontier from well-known companies such as Composite Resources, Ferno, Vidacare, American Diagnostic Corporation and North American Rescue. Products in the range include those for emergency care, resuscitation and oxygen, patient transport and emergency medical training, and cover items such as stethoscopes, many different types of stretchers and oxygen masks.

Following the acquisition Frontier’s sales, marketing and customer service team of five will move to Pharmaco’s head office in Mount Wellington, Auckland, and will operate as a separate business unit within Pharmaco (NZ) Limited.

Chandra Selvadurai, CEO of Pharmaco, says the acquisition has been a meeting of minds between two very successful home-grown healthcare companies who both understand the New Zealand market very well:

“This is a great fit for Pharmaco and offers us a new avenue for growth in both the pre-hospital market in emergency care, rescue, resuscitation and trauma, and the hospital sector.

“The products distributed by Frontier are critical for any emergency situation, which means efficient supply and distribution to emergency personnel is an incredibly important task. Combining the expertise of the Frontier team with Pharmaco’s almost 50 years of experience in medical product distribution means emergency personnel, and the New Zealanders or visitors they serve, will have the best access to the best equipment when they need it the most.”

“It makes me even more delighted that the entire Frontier team will be joining us bringing their vital skills and knowledge with them. This includes the founders, Warwick Manning, a former emergency professional, and Karen Angove, who will join us as consultants during the transition,” he says.

Frontier’s range of products are used across New Zealand by personnel including around 4,000 paid and volunteer people from St John Ambulance and Wellington Free Ambulance, and over 10,000 career and volunteer fire fighters from the NZ Fire Service, District and City Councils and the Department of Conservation. They are also used in hospitals and health centres nationwide.

Both companies have successfully carved a niche in the New Zealand market by representing international companies.

Pharmaco was established in 1967 and has built up a reputation as a highly professional operator in the pharmaceutical, diagnostic, scientific and medical product sector. It will now manage the sales, marketing and distribution for over 2500 products and represents over twenty international pharmaceutical and medical technology companies from around the world.

Frontier Medical was established in 1999 and is at the forefront of supplying quality emergency care, resuscitation and training equipment. The business has developed a reputation for having the most comprehensive range of emergency equipment in this sector.

Chandra Selvadurai continues by explaining the importance of the healthcare sales, marketing and distribution sector:

“New Zealand is reliant on international healthcare products to serve its population and visitors. But this wouldn’t be possible without companies like Pharmaco and Frontier who represent international companies, and their products, without the need for them to have a local presence.

“This is where highly skilled sales, marketing and distribution, along with administration and regulatory support, becomes such an important service and where being a New Zealand company makes all the difference, simply because we understand the market better.”

Ends

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Industry Report: Growing Interactive Sector Wants Screen Grants

Introducing a coordinated plan that invests in emerging talent and allows interactive media to access existing screen industry programmes would create hundreds of hi-tech and creative industry jobs. More>>

ALSO:

Ground Rules: Government Moves To Protect Best Growing Land

“Continuing to grow food in the volumes and quality we have come to expect depends on the availability of land and the quality of the soil. Once productive land is built on, we can’t use it for food production, which is why we need to act now.” More>>

ALSO:

Royal Society: Calls For Overhaul Of Gene-Technology Regulations

An expert panel considering the implications of new technologies that allow much more controlled and precise ‘editing’ of genes, has concluded it’s time for an overhaul of the regulations and that there’s an urgent need for wide discussion and debate about gene editing... More>>

ALSO:

Retail: Card Spending Dips In July

Seasonally-adjusted electronic card spending dipped in July by 0.1 percent after being flat in June, according to Stats NZ. Economists had expected a 0.5 percent lift, according to the median in a Bloomberg poll. More>>

ALSO:

Product Stewardship: Govt Takes More Action To Reduce Waste

The Government is proposing a new way to deal with environmentally harmful products before they become waste, including plastic packing and bottles, as part of a wider plan to reduce the amount of rubbish ending up in landfills. More>>

ALSO:

Earnings Update: Fonterra Sees Up To $675m Loss On Writedowns

“While the Co-op’s FY19 underlying earnings range is within the current guidance of 10-15 cents per share, when you take into consideration these likely write-downs, we expect to make a reported loss of $590-675 million this year, which is a 37 to 42 cent loss per share." More>>

ALSO: